Humacyte, Inc. Revenue 2024–2025
Humacyte, Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Humacyte, Inc. revenue for the quarter ending March 31, 2026 was 495000, a 4.26% decrease year-over-year.
- Humacyte, Inc. revenue for the twelve months ending March 31, 2026 was 2.1 M, a 757.26% increase year-over-year.
- Humacyte, Inc. annual revenue for 2025 was 2.0 M.
- Humacyte, Inc. annual revenue for 2024 was 0.
Humacyte, Inc. (HUMA) — Frequently Asked Questions
Humacyte, Inc. (HUMA) is a publicly traded US company. It has a market capitalization of $165M. In fiscal 2025 it reported revenue of $2M and net income of -$41M. Explore HUMA's stock price, financial statements, earnings history, margins and key ratios below.
What is Humacyte, Inc.'s market cap?
Humacyte, Inc. (HUMA) has a market capitalization of $165M.
What is the HUMA stock price?
HUMA trades at $1.04 (-22.01% on the day).
How much revenue does Humacyte, Inc. make?
Humacyte, Inc. reported revenue of $2M in fiscal 2025.
Is HUMA profitable?
In fiscal 2025, Humacyte, Inc. reported net income of -$41M.